Beltsville, MD, USA: 2014
Horvatits T, Tamminga M, Liu B, Sebode M, Carambia A, Fischer L, et al
Based on the positive outcomes of the ECOSPOR III trial (SER-109 versus Placebo in the Treatment of Adults with Recurrent Clostridium difficile Infection), the United States Food and Drug Administration (FDA) recently approved SER-109 174 , the first oral fecal microbiota drug
008_2025_PTE_RK/36) and by the Jnos Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00750/22/5) to VK
Injectable hair protocol: Dose: 1-2mg daily Frequency: Daily or 5 days weekly Duration: 16-24 weeks minimum (longer than anti-aging protocols) Cycle: 8 weeks on, 4 weeks off, repeat Topical scalp protocol: Concentration: 0.5% solution Application: 1-2ml to thinning areas twice daily Duration: 6+ months for meaningful assessment Technique: Apply to clean, dry scalp